Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aqumen Biopharmaceuticals, N.A.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have a cataract sufficiently opaque/mature/brunescent that, in the surgeon's assessment,a dye could facilitate surgery;
Be aged at least 18 years old at the time of enrollment;
Be in a medical condition suitable for cataract surgery;
Able and willing to participate in study examinations and visit schedule; and
Understand and freely consent to participate in the study.
You may not be if
In either eye, ocular infection or inflammation within the past 3 months;
Known allergy to BBG 250;
Uncontrolled intercurrent diseases including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, or cardiac arrhythmia;
Active treatment for cancer or systemic infection within the past month;
Active treatment with systemic corticosteroids within the past month;
Previous participation in this Study for the contralateral eye;
Participation in another clinical trial involving an investigational therapeutic during the past 30 days or 5.5 half-lives (if applicable), whichever is longer;
Unwillingness to participate in the study or inability to give informed consent; or
Any medical condition that in the opinion of the Investigator may compromise the research subject's safety or ability to participate in the study.
Clareo Health | DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery
